SYL2158 has great selectivity for the degradation of NSD3 and effectively down-regulates the expression of H3K36 methylation and cell proliferation-related genes in lung cancer cells, which is more effective in inhibiting cell growth than NSD3-PWWP antagonist in lung cancer cells. Here, NSD3 is linked to lung cancer.